| Baltimore Sleeps Better Llc | |
|
1 E Chase St Ste R3l Baltimore MD 21202-2526 | |
| (443) 438-6890 | |
| Not Available |
| Full Name | Baltimore Sleeps Better Llc |
|---|---|
| Speciality | Dentist |
| Location | 1 E Chase St Ste R3l, Baltimore, Maryland |
| Authorized Official Name and Position | John K Taylor (OWNER) |
| Authorized Official Contact | 4434386890 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Baltimore Sleeps Better Llc 1 East Chase Street Suite R3l Box 5 Baltimore MD 21202-2526 Ph: (443) 438-6890 | Baltimore Sleeps Better Llc 1 E Chase St Ste R3l Baltimore MD 21202-2526 Ph: (443) 438-6890 |
| NPI Number | 1063182749 |
|---|---|
| Provider Enumeration Date | 09/15/2021 |
| Last Update Date | 04/26/2024 |
| Medicare PECOS PAC ID | 0143628677 |
|---|---|
| Medicare Enrollment ID | O20211013001510 |
News Archive
Beckman Coulter Life Sciences expands services by placing DURA Innovations dry reagent solutions at the heart of enhanced external business resources for lab.
RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.
"Business groups are continuing their air war against the health care overhaul efforts as Congressional Democrats inch closer to crafting the final plan." The coalition is led by the U.S. Chamber of Commerce, which released new TV spots Thursday.
A recent study by US researchers shows how the 501Y.V2 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), characterized by several mutations, is able to escape neutralization by present first-wave anti-SARS-CoV-2 antibodies and potentially re-infect COVID-19 convalescent individuals.
Pfizer Inc. and Auxilium Pharmaceuticals, Inc. today announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's contracture (a condition resulting in the contracture of the fingers into the palm), has completed the validation phase successfully. As a result, the scientific/technical review procedure commenced on 21 January 2010.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063182749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | (* (Not Available)) | Primary |
News Archive
Beckman Coulter Life Sciences expands services by placing DURA Innovations dry reagent solutions at the heart of enhanced external business resources for lab.
RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.
"Business groups are continuing their air war against the health care overhaul efforts as Congressional Democrats inch closer to crafting the final plan." The coalition is led by the U.S. Chamber of Commerce, which released new TV spots Thursday.
A recent study by US researchers shows how the 501Y.V2 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), characterized by several mutations, is able to escape neutralization by present first-wave anti-SARS-CoV-2 antibodies and potentially re-infect COVID-19 convalescent individuals.
Pfizer Inc. and Auxilium Pharmaceuticals, Inc. today announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren's contracture (a condition resulting in the contracture of the fingers into the palm), has completed the validation phase successfully. As a result, the scientific/technical review procedure commenced on 21 January 2010.
› Verified 2 days ago
Kelvin B. Smith, Dds, Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 7008 Security Blvd, Suite 110, Baltimore, MD 21244 Phone: 410-277-9206 Fax: 410-277-9209 | |
Small Smiles Dental Center Of Central Baltimore, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 921 N Caroline St, Baltimore, MD 21205 Phone: 615-750-0343 | |
Bk Faithful Enterprises Consulting Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3120 Lord Baltimore Dr Ste 100, Baltimore, MD 21244 Phone: 410-623-7381 | |
Smile Rotunda Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 711 W 40th St Ste 213, Baltimore, MD 21211 Phone: 410-889-7100 Fax: 410-889-7111 | |
Drs Russell & Nicholas-holmes Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4714 Edmondson Avenue, Baltimore, MD 21229 Phone: 410-566-4200 Fax: 410-566-1770 | |
Kings Court Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 9516 Philadelphia Rd, Kings Court Family Dentistry, Baltimore, MD 21237 Phone: 410-391-9565 Fax: 410-391-7458 | |
Mishpacha Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3635 Old Court Rd, Baltimore, MD 21208 Phone: 410-484-2717 Fax: 443-519-4078 |